In laboratory monitoring, the improvement in liver enzymes among alcoholics was significant. During treatment, patients' gamma-GT decreased from 133.6 IU/l to 71.0 IU/l (see figure). Other liver enzymes also showed a statistically significant improvement.
78% of the clients who received treatment succeeded in either reaching the WHO's moderate consumption limit or cutting their alcohol intake in half.
Analysis of the data collected from our clinics shows that the reduction in the amount of alcohol drunk and the cravings for alcohol was statistically significant (p<0.001)
Read moreMood was also found to improve significantly with the treatment. On the Beck’s Depression Scale, patients' mood averaged 8.2 points at baseline (equivalent to moderate depression) and 3.6 (normal mood) at the end of treatment.
Diagnosing an alcohol problem involves laboratory tests that assess liver enzymes. Alcoholics typically exhibit significantly elevated liver enzymes, which increases the risk of liver diseases like cirrhosis.
Within a few weeks of abstaining from alcohol, the liver enzymes of individuals with alcoholism begin to show improvement. Our treatment aims to normalise these elevated liver enzymes to reduce the associated health risks.
Gamma-GT is the most commonly used laboratory test to measure high alcohol consumption, although it alone cannot reliably indicate alcoholism, as opposed to an Audit-10 survey interpreted by a professional. The decrease in Gamma-GT, as shown in the graph below, indicates reduced alcohol consumption. During Contral treatment, patients experienced a significant improvement in their liver enzymes, with gamma-GT decreasing from 133.6 IU/l to 71.0 IU/l.
The alcohol problem usually starts to diminish early in the treatment process, with a distinct reduction in alcohol consumption towards the end of the programme.
The graph below illustrates the decline in alcohol consumption following the start of the treatment program. Even within the first weeks of treatment, a significant decrease in alcohol consumption is observed. The reference point for comparison is the average consumption during the two weeks prior to beginning the treatment
Cravings for alcohol can present a significant challenge during the recovery process from alcoholism. Alcohol is often sought for its pleasurable effects, and a key objective of treatment is to foster alternative sources of pleasure, replacing the reliance on alcohol.
The client's alcohol craving is measured using the VAS (Visual Analogue Scale). The graph below illustrates a clear and statistically significant decline in the desire to consume alcohol as the Contral treatment program progresses, from the initial session to the final session.
Excessive alcohol consumption often acts as a trigger for depression. Alcohol's detrimental impact includes various psychological consequences, such as anxiety, restlessness, mood swings, and feelings of sadness. These effects tend to intensify with increased alcohol intake.
The clients' mood is measured with the commonly utilised Beck's Depression Inventory (BDI). A study (n=220) showed a significant improvement in mood. At the beginning of treatment, clients exhibited an average mood score indicative of moderate depression (8.2 points), but by the end of treatment it had improved to normal mood (3.6 points).
Gender
Men 76%
Women 24%
Previous treatments for alcohol problems
Yes 53%
No 29%
Missing information 18%
Age
Youngest
Average
Oldest
Starting point
CAGE
DSMIIR
At the beginning of treatment, 97% of patients were found to have an alcohol problem according to the CAGE definition, and 92% were found to have an alcohol problem according to the DSMIIR definition.
Contral Clinics' highly experienced doctors and psychologists have successfully supported thousands of clients from all backgrounds in overcoming addiction, enabling them to regain control over their lives and achieve a balanced work and family life. In order to maintain patient safety and privacy, the names of client testimonials have been changed.